Ahead Therapeutics SL
A tech-platform developing disease-modifying treatments to cure autoimmune diseases
Product patent. Claim 1: “A liposome encapsulating an autoantigen, wherein (i) the liposomes has a size comprised from 500 to 15000 nm; and (ii) the liposome membrane comprises phosphatidylserine (PS) in an amount comprised from 10 to 40% by weight with respect to the total membrane liposomal composition.”
Product patent. TOLEROGENIC COMPOSITION. Based on the innovative features discovered during the development of the Ahead’s Tech-Platform. It is based on the involvement of B Cells and scalable method of liposomes production process.
Under evaluation at least till: 25th of June 2023